Ausgabe 1/2008
Inhalt (14 Artikel)
Anti-cancer therapies targeting the tumor stroma
Valeska Hofmeister, David Schrama, Jürgen C. Becker
Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects
Diana Llopiz, Javier Dotor, Aintzane Zabaleta, Juan J. Lasarte, Jesús Prieto, Francisco Borrás-Cuesta, Pablo Sarobe
Immunological profiling of a panel of human ovarian cancer cell lines
Tiffany M. Carr, Sara J. Adair, Mitsú J. Fink, Kevin T. Hogan
A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells
P. Bühler, P. Wolf, D. Gierschner, I. Schaber, A. Katzenwadel, W. Schultze-Seemann, U. Wetterauer, M. Tacke, M. Swamy, W. W. A. Schamel, U. Elsässer-Beile
HLA-DPB1 supertype-associated protection from childhood leukaemia: relationship to leukaemia karyotype and implications for prevention
Malcolm Taylor, Christine Harrison, Tim Eden, Jillian Birch, Mel Greaves, Tracy Lightfoot, Adiba Hussain
Activation and route of administration both determine the ability of bone marrow-derived dendritic cells to accumulate in secondary lymphoid organs and prime CD8+ T cells against tumors
Stephanie P. Huck, Shiau-Choot Tang, Kate A. Andrew, Jianping Yang, Jacquie L. Harper, Franca Ronchese
Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation
Atsuko Fujihara, Masayuki Kurooka, Tsuneharu Miki, Yasufumi Kaneda
Immunological tumor destruction in a murine melanoma model by targeted LTα independent of secondary lymphoid tissue
David Schrama, Heike Voigt, Andreas O. Eggert, Rong Xiang, He Zhou, Ton N. M. Schumacher, Mads H. Andersen, Per thor Straten, Ralph A. Reisfeld, Jürgen C. Becker
Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma
Femke Hillen, Coen I. M. Baeten, Anouk van de Winkel, David Creytens, Daisy W. J. van der Schaft, Véronique Winnepenninckx, Arjan W. Griffioen
Ethnic differences in cytokine gene polymorphisms: potential implications for cancer development
Jovanny Zabaleta, Barbara G. Schneider, Kelli Ryckman, Pleasant F. Hooper, M. Constanza Camargo, M. Blanca Piazuelo, Rosa A. Sierra, Elizabeth T. H. Fontham, Pelayo Correa, Scott M. Williams, Augusto C. Ochoa
EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cells
Hidenobu Ochiai, Gary E. Archer, James E. Herndon II, Chien-Tsun Kuan, Duane A. Mitchell, Darell D. Bigner, Ira H. Pastan, John H. Sampson
Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy
Justin T. Jordan, Wei Sun, S. Farzana Hussain, Guillermo DeAngulo, Sujit S. Prabhu, Amy B. Heimberger
Preferential migration of regulatory T cells mediated by gliomasecreted chemokines can be blocked with chemotherapy
Justin T. Jordan, Wei Sun, S. Farzana Hussain, Guillermo DeAngulo, Sujit S. Prabhu, Amy B. Heimberger
Report on the Fifth Annual Meeting of the Association for Immunotherapy of Cancer (CIMT) April 12–14, 2007 in Würzburg, Germany
Marij J. P. Welters, Cécile Gouttefangeas, Sebastian Attig, Sven Koch, Cedrik M. Britten